| |
| |
|
| Insider
Information: |
Eisenstadt Richard I |
| Relationship: |
Chief Financial Officer |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
45,012 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$322,286 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
45,012 |
|
|
| Total
Value |
$322,286 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 20.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neos Therapeutics, Inc. |
NEOS |
Chief Financial Officer |
2021-03-19 |
0 |
2016-08-25 |
0 |
Premium* |
|
|
Altimmune, Inc |
ALT |
Chief Financial Officer |
2024-01-31 |
45,012 |
2022-07-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALT |
Altimmune, Inc |
Chief Financial Officer |
• – – |
2024-01-31 |
4 |
A |
$2.69 |
$12,430 |
D/D |
4,621 |
45,012 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Chief Financial Officer |
• – – |
2024-01-30 |
4 |
D |
$9.80 |
$21,315 |
D/D |
(2,175) |
40,391 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Chief Financial Officer |
• – – |
2024-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,275 |
42,566 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Chief Financial Officer |
• – – |
2023-12-29 |
4 |
D |
$11.25 |
$34,245 |
D/D |
(3,044) |
33,291 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Chief Financial Officer |
• – – |
2023-12-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
36,335 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Chief Financial Officer |
• – – |
2023-07-31 |
4 |
A |
$2.81 |
$5,128 |
D/D |
1,825 |
23,835 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Chief Financial Officer |
• – – |
2023-03-24 |
4 |
B |
$4.31 |
$43,140 |
D/D |
10,000 |
22,010 |
2.74 |
% |
|
| ALT |
Altimmune, Inc |
Chief Financial Officer |
• – – |
2023-01-31 |
4 |
A |
$10.21 |
$11,964 |
D/D |
1,172 |
12,010 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Chief Financial Officer |
• – – |
2022-12-31 |
4 |
D |
$16.45 |
$49,811 |
D/D |
(3,028) |
10,838 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Chief Financial Officer |
• – – |
2022-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
13,866 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Chief Financial Officer |
• – – |
2022-07-31 |
4 |
A |
$6.86 |
$9,371 |
D/D |
1,366 |
1,366 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-03-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(126,245) |
0 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-03-02 |
4 |
D |
$0.84 |
$12,512 |
D/D |
(14,825) |
126,245 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-03-01 |
4 |
D |
$0.88 |
$1,227 |
D/D |
(1,390) |
141,070 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
0 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-12-12 |
4 |
B |
$2.16 |
$10,820 |
D/D |
5,000 |
42,460 |
2.74 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,750 |
37,460 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2017-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
18,710 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2016-08-25 |
4 |
B |
$6.82 |
$25,284 |
D/D |
3,710 |
3,710 |
2.74 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
